Cas 200801-21-4,4-[5-(2-METHYLAMINOPYRIMIDIN-4-YL)-4-(3-TRIFLUOROMETHYLPHENYL)-1H-IMIDAZOL-2-YL]-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

200801-21-4

Post Buying Request

Basic information

Product Name: 4-[5-(2-METHYLAMINOPYRIMIDIN-4-YL)-4-(3-TRIFLUOROMETHYLPHENYL)-1H-IMIDAZOL-2-YL]-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
Synonyms:
CAS NO:200801-21-4
Molecular Formula:
Molecular Weight: 536.557
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[5-(2-METHYLAMINOPYRIMIDIN-4-YL)-4-(3-TRIFLUOROMETHYLPHENYL)-1H-IMIDAZOL-2-YL]-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(CAS DataBase Reference)
NIST Chemistry Reference: 4-[5-(2-METHYLAMINOPYRIMIDIN-4-YL)-4-(3-TRIFLUOROMETHYLPHENYL)-1H-IMIDAZOL-2-YL]-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(200801-21-4)
EPA Substance Registry System: 4-[5-(2-METHYLAMINOPYRIMIDIN-4-YL)-4-(3-TRIFLUOROMETHYLPHENYL)-1H-IMIDAZOL-2-YL]-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(200801-21-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 200801-21-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

200801-21-4 Suppliers

Recommended suppliers

200801-21-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 200801-21-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,0,8,0 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 200801-21:
(8*2)+(7*0)+(6*0)+(5*8)+(4*0)+(3*1)+(2*2)+(1*1)=64
64 % 10 = 4
So 200801-21-4 is a valid CAS Registry Number.

200801-21-4Upstream product

200801-21-4Downstream Products

200801-21-4Relevant academic research and scientific papers

MODULATORS OF HCV REPLICATION

-

Page/Page column 7, (2008/06/13)

The present invention is directed to the use of certain 2,4,5-trisubstituted imidazole derivatives in modulating the replication of Hepatitis C virus RNA and/or virus production in cells.

SUBSTITUTED IMIDAZOLES HAVING CYTOKINE INHIBITORY ACTIVITY

-

Page/Page column 29, (2010/02/11)

Compounds represented by formula I: I are disclosed. AR represents an aromatic group containing 6-10 atoms; and represents a 4 to 10 membered non-aromatic heterocycle containing at least one N atom, and optionally containing 1-2 additional

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 200801-21-4